Status: Recruiting
A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
This is a clinical study of personalized self-DC vaccine targeting neo-antigen (Neo-DC vaccine) in the treatment of advanced solid tumors.
Participants needed: 9
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Apr 2, 2026Locations: 1
Eligibility criteria
18-75 years. [+11]
Pregnant or lactating women. [+12]